231 related articles for article (PubMed ID: 22343492)
1. Cancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancer.
Shiraishi T; Getzenberg RH; Kulkarni P
Asian J Androl; 2012 May; 14(3):400-4. PubMed ID: 22343492
[TBL] [Abstract][Full Text] [Related]
2. Cancer/Testis Antigens: "Smart" Biomarkers for Diagnosis and Prognosis of Prostate and Other Cancers.
Kulkarni P; Uversky VN
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362316
[TBL] [Abstract][Full Text] [Related]
3. Nanowire analysis of cancer-testis antigens as biomarkers of aggressive prostate cancer.
Takahashi S; Shiraishi T; Miles N; Trock BJ; Kulkarni P; Getzenberg RH
Urology; 2015 Mar; 85(3):704.e1-7. PubMed ID: 25733303
[TBL] [Abstract][Full Text] [Related]
4. Expression of cancer/testis antigens in prostate cancer is associated with disease progression.
Suyama T; Shiraishi T; Zeng Y; Yu W; Parekh N; Vessella RL; Luo J; Getzenberg RH; Kulkarni P
Prostate; 2010 Dec; 70(16):1778-87. PubMed ID: 20583133
[TBL] [Abstract][Full Text] [Related]
5. Cancer/Testis Antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy.
Shiraishi T; Terada N; Zeng Y; Suyama T; Luo J; Trock B; Kulkarni P; Getzenberg RH
J Transl Med; 2011 Sep; 9():153. PubMed ID: 21917134
[TBL] [Abstract][Full Text] [Related]
6. Cancer/testis antigen SPATA19 is frequently expressed in benign prostatic hyperplasia and prostate cancer.
Wong KK; Hussain FA; Loo SK; López JI
APMIS; 2017 Dec; 125(12):1092-1101. PubMed ID: 28972294
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy.
Faramarzi S; Ghafouri-Fard S
Immunotherapy; 2017 Sep; 9(12):1019-1034. PubMed ID: 28971747
[TBL] [Abstract][Full Text] [Related]
8. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
[TBL] [Abstract][Full Text] [Related]
9. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.
Gordeeva O
Semin Cancer Biol; 2018 Dec; 53():75-89. PubMed ID: 30171980
[TBL] [Abstract][Full Text] [Related]
10. Derepression of Cancer/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation.
Kim R; Kulkarni P; Hannenhalli S
BMC Cancer; 2013 Mar; 13():144. PubMed ID: 23522060
[TBL] [Abstract][Full Text] [Related]
11. Expression of Cancer-Testis Antigens in Pediatric Cancers.
Ghafouri-Fard S
Asian Pac J Cancer Prev; 2015; 16(13):5149-52. PubMed ID: 26225644
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential value of Cancer-testis antigens in immunotherapy of gastric cancer.
Alsadat Mahmoudian R; Amirhosein M; Mahmoudian P; Fardi Golyan F; Mokhlessi L; Maftooh M; Khazaei M; Nassiri M; Mahdi Hassanian S; Ghayour-Mobarhan M; Ferns GA; Shahidsales S; Avan A
Gene; 2023 Feb; 853():147082. PubMed ID: 36464170
[TBL] [Abstract][Full Text] [Related]
13. Novel centrosome protein, TCC52, is a cancer-testis antigen.
Li S; Hu X; Cui S; He D
Cancer Sci; 2008 Nov; 99(11):2274-9. PubMed ID: 18957058
[TBL] [Abstract][Full Text] [Related]
14. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
15. Roles of cancer/testis antigens (CTAs) in breast cancer.
Li Y; Li J; Wang Y; Zhang Y; Chu J; Sun C; Fu Z; Huang Y; Zhang H; Yuan H; Yin Y
Cancer Lett; 2017 Jul; 399():64-73. PubMed ID: 28274891
[TBL] [Abstract][Full Text] [Related]
16. Humoral immune responses to testis antigens in sera from patients with prostate cancer.
Hoeppner LH; Dubovsky JA; Dunphy EJ; McNeel DG
Cancer Immun; 2006 Jan; 6():1. PubMed ID: 16401063
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
Yang P; Meng M; Zhou Q
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
[TBL] [Abstract][Full Text] [Related]
18. The role of Cancer/Testis Antigens in Multiple Myeloma pathogenesis and their application in disease monitoring and therapy.
Shires K; Van Wyk T
Crit Rev Oncol Hematol; 2018 Dec; 132():17-26. PubMed ID: 30447924
[TBL] [Abstract][Full Text] [Related]
19. Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.
Adeola HA; Smith M; Kaestner L; Blackburn JM; Zerbini LF
Oncotarget; 2016 Mar; 7(12):13945-64. PubMed ID: 26885621
[TBL] [Abstract][Full Text] [Related]
20. Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.
Djureinovic D; Dodig-Crnković T; Hellström C; Holgersson G; Bergqvist M; Mattsson JSM; Pontén F; Ståhle E; Schwenk JM; Micke P
Lung Cancer; 2018 Nov; 125():157-163. PubMed ID: 30429015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
